Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inkbit is a private advanced manufacturing company developing and commercializing industrial 3D printing systems, digital manufacturing services, materials, and software. The company was spun out of MIT and built its core platform around Vision-Controlled Jetting, a closed-loop additive manufacturing process that combines inkjet deposition, real-time 3D machine vision, and feedback control. Inkbit markets the Vista production system, the Construct build-preparation software workflow, and a growing portfolio of multi-material polymers including elastomeric, epoxy, and RF/microwave-oriented materials. Its services are aimed at producing complex end-use polymer parts for industries such as medical devices, robotics, wearables, industrial systems, and RF applications. Although it may serve healthcare and medical device customers, Inkbit is not primarily a biotech, pharma, or healthcare therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inkbit.